Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,BST2,Bone marrow stromal antigen 2,51452,826,1.27 [1.15-1.41],5.285755991078135e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,CHGA,Chromogranin-A,44356,705,1.20 [1.12-1.28],2.796051471875736e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,CKAP4,Cytoskeleton-associated protein 4,51313,824,1.67 [1.37-2.03],3.883729162226416e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,COL6A3,Collagen alpha-3(VI) chain,51632,829,1.49 [1.27-1.76],1.8962644412512624e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,CTSO,Cathepsin O,51562,830,1.60 [1.32-1.93],1.5070695259590283e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",51158,822,1.53 [1.29-1.82],1.3842548569184922e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,EDA2R,Tumor necrosis factor receptor superfamily member 27,51440,831,1.47 [1.26-1.72],1.280328385296832e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,EFNA1,Ephrin-A1,50930,813,1.61 [1.31-1.98],6.5420297672406805e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,GAST,Gastrin,44244,702,1.17 [1.12-1.23],1.1669544095711512e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,GDF15,Growth/differentiation factor 15,51632,829,1.57 [1.41-1.75],4.826989257491562e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,HAVCR1,Hepatitis A virus cellular receptor 1,51366,829,1.26 [1.15-1.39],6.204049448162769e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,ITGA11,Integrin alpha-11,50932,826,0.63 [0.53-0.76],5.345911093740032e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,ITGAV,Integrin alpha-V,51440,831,0.43 [0.30-0.61],3.5922908546537256e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,LGALS4,Galectin-4,50975,827,1.29 [1.16-1.43],3.5699813384910017e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,LGALS9,Galectin-9,50976,824,1.57 [1.30-1.88],2.159966636019226e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,LGMN,Legumain,51225,828,1.48 [1.26-1.75],2.855020955940652e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,NEFL,Neurofilament light polypeptide,49648,792,1.48 [1.30-1.68],1.5486388705059951e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,NOS3,"Nitric oxide synthase, endothelial",49806,795,1.28 [1.16-1.41],1.0750558708057093e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,NTproBNP,N-terminal prohormone of brain natriuretic peptide,51002,822,1.15 [1.09-1.21],6.502459036012748e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,PALM2,Paralemmin-2,44244,702,1.56 [1.32-1.85],3.431471506912172e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,PIGR,Polymeric immunoglobulin receptor,50349,807,1.49 [1.26-1.75],2.7206003130725734e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,PLAUR,Urokinase plasminogen activator surface receptor,50640,823,1.75 [1.41-2.17],3.186166627017079e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,RARRES2,Retinoic acid receptor responder protein 2,51289,825,1.31 [1.16-1.47],8.76301281108375e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,SPINK1,Serine protease inhibitor Kazal-type 1,51015,816,1.38 [1.21-1.58],2.039021504581829e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,SPON2,Spondin-2,50760,820,1.53 [1.28-1.82],1.7515737120471732e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,TFF2,Trefoil factor 2,51143,827,1.29 [1.16-1.42],9.354497690819484e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,TFF3,Trefoil factor 3,50953,823,1.34 [1.20-1.49],2.643862088512116e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,50607,812,1.61 [1.37-1.89],6.562933214621199e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,50607,812,1.26 [1.15-1.39],1.242093264941037e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,UMOD,Uromodulin,51470,828,0.77 [0.69-0.86],2.0062370843666084e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,VSIG2,V-set and immunoglobulin domain-containing protein 2,44142,706,1.35 [1.21-1.49],2.009250527217542e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,WFDC2,WAP four-disulfide core domain protein 2,48407,777,1.44 [1.24-1.67],1.3700171267080546e-06
